- Home
- ATOS vs MPU Comparison
ATOS vs MPU Comparison
Compare ATOS & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATOS | MPU |
|---|---|---|
| Founded | 2009 | 1989 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.2M | 42.4M |
| IPO Year | 2010 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ATOS | MPU |
|---|---|---|
| Price | $4.91 | $0.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 43.8K | ★ 49.3K |
| Earning Date | 05-13-2026 | 04-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,758.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $0.50 |
| 52 Week High | $7.56 | $4.44 |
Technical Indicators
Market Signals| Indicator | ATOS | MPU |
|---|---|---|
| Relative Strength Index (RSI) | 42.27 | 42.17 |
| Support Level | $4.59 | $0.50 |
| Resistance Level | $5.12 | $0.78 |
| Average True Range (ATR) | 0.32 | 0.06 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 15.86 | 24.55 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About MPU Mega Matrix Corp.
Mega Matrix Corp is a holding company that offers investors an opportunity to participate in the growth of stablecoins, one of the fastest-evolving sectors in digital assets. The company generated revenue from the Membership and top-up streaming services revenue, Online advertising services, and Content licensing. Geographically, the company operates in the United States and Canada, Asia Pacific, Europe middle east and Africa, and Latin America.